AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+1%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.33B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$211M |
| 2 |
Cigna
CI
|
+$198M |
| 3 |
Comcast
CMCSA
|
+$163M |
| 4 |
Zoom
ZM
|
+$148M |
| 5 |
Johnson & Johnson
JNJ
|
+$136M |
Top Sells
| 1 |
Humana
HUM
|
+$263M |
| 2 |
TSMC
TSM
|
+$245M |
| 3 |
NVIDIA
NVDA
|
+$168M |
| 4 |
Adobe
ADBE
|
+$151M |
| 5 |
Pultegroup
PHM
|
+$120M |
Sector Composition
| 1 | Technology | 24.6% |
| 2 | Financials | 13.87% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Industrials | 12.41% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Iovance Biotherapeutics
IOVA
$861M
| $92K | ﹤0.01% |
11,477
-28,534
| -71% | -$229K |
|
2502
Cardlytics
CDLX
$49.8M
| $91.9K | ﹤0.01% |
11,192
-1,056
| -9% | -$8.67K |
|
2503
Origin Materials
ORGN
$80.2M
| $89.2K | ﹤0.01% |
98,969
+77,119
| +353% | +$69.5K |
|
2504
Redwire
RDW
$1.19B
| $89K | ﹤0.01% |
+12,415
| New | +$89K |
|
2505
Grifois
GRFS
$6.7B
| $88.9K | ﹤0.01% |
+14,107
| New | +$88.9K |
|
2506
Turkcell
TKC
$4.79B
| $88.5K | ﹤0.01% |
+11,678
| New | +$88.5K |
|
|
PGRE
2507
Paramount Group
PGRE
$1.6B
| $87K | ﹤0.01% |
19,203
+1,647
| +9% | +$7.46K |
|
2508
Oric Pharmaceuticals
ORIC
$1.02B
| $86.5K | ﹤0.01% |
12,241
-2,057
| -14% | -$14.5K |
|
|
IGMS
2509
DELISTED
IGM Biosciences
IGMS
| $84K | ﹤0.01% |
+12,230
| New | +$84K |
|
2510
ESS Tech
GWH
$20.8M
| $83.6K | ﹤0.01% |
+6,817
| New | +$83.6K |
|
|
VTNR
2511
DELISTED
Vertex Energy, Inc
VTNR
| $83.5K | ﹤0.01% |
88,398
-1,228,767
| -93% | -$1.16M |
|
2512
Archer Aviation
ACHR
$5.32B
| $83.2K | ﹤0.01% |
23,648
-470
| -2% | -$1.65K |
|
|
ADAM
2513
Adamas Trust, Inc. Common Stock
ADAM
$659M
| $83K | ﹤0.01% |
+14,215
| New | +$83K |
|
2514
Precigen
PGEN
$1.22B
| $79K | ﹤0.01% |
50,002
+18,097
| +57% | +$28.6K |
|
2515
SGHC Ltd
SGHC
$6.57B
| $77.3K | ﹤0.01% |
+23,919
| New | +$77.3K |
|
2516
Outlook Therapeutics
OTLK
$44.4M
| $75K | ﹤0.01% |
+10,164
| New | +$75K |
|
2517
Hanesbrands
HBI
$2.21B
| $74.8K | ﹤0.01% |
15,741
+752
| +5% | +$3.58K |
|
2518
Clarus
CLAR
$149M
| $72.8K | ﹤0.01% |
10,811
-155,160
| -93% | -$1.04M |
|
2519
MiMedx Group
MDXG
$1.02B
| $71.8K | ﹤0.01% |
10,365
-8,039
| -44% | -$55.7K |
|
2520
Blue Ridge Bankshares
BRBS
$380M
| $71.6K | ﹤0.01% |
+27,446
| New | +$71.6K |
|
2521
CS Disco
LAW
$343M
| $71.1K | ﹤0.01% |
11,933
-9,284
| -44% | -$55.3K |
|
2522
Pulmonx
LUNG
$65.6M
| $70.1K | ﹤0.01% |
11,059
-48,671
| -81% | -$309K |
|
2523
Evolv Technologies
EVLV
$1.37B
| $69.6K | ﹤0.01% |
27,312
-409,686
| -94% | -$1.04M |
|
2524
PLAYSTUDIOS Inc
MYPS
$120M
| $67.7K | ﹤0.01% |
+32,716
| New | +$67.7K |
|
|
LICY
2525
DELISTED
Li-Cycle Holdings Corp.
LICY
| $67.4K | ﹤0.01% |
10,318
+7,988
| +343% | +$52.2K |
|